Skip to main content

Basel startup Nutrix beats 900 startups

| News

Basel startup Nutrix beats 900 startups

11.11.2019

The Basel startup Nutrix has won a competition at the Web Summit with its business concept. It has developed a nanosensor that measures glucose levels in users’ saliva to prevent diabetes. Nutrix is supported by the Venture Mentoring program of BaselArea.swiss and has been shortlisted for the DayOne Accelerator.

Maria Hahn, Founder of Nutrix, on Center Stage of Web Summit 2019

According to an article at startupticker.ch, the Web Summit, one of the largest annual conferences for the global technology industry, took place in the first week of November. During the conference a competition for start-ups was also held, enabling them to present their business concept. This year, around 900 startups took part, and the winner was the Basel-based Medtech startup Nutrix.

It has developed a nanosensor that is placed on the tooth to measure glucose levels in users’ saliva and transfers information to an external app. At the same time, the sensor tracks food intake and provides dietary tips on this basis, allowing it to be used to prevent diabetes. Co-founder Maria Hahn underlined during the presentation that preventative measures such as these could shape the future of medicine.

Hahn and the second co-founder Nikjil Singh first developed their idea together in spring this year. They are already working towards building a prototype. Nutrix has close links with Basel Children’s Hospital (UKBB).

With decades of expertise in healthcare and mechanics, the Basel Area has become a sought-after location for medtech startups.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.